Adenovirus

Image of a neon sign with the word no lit up next to an unlit yes
Biotech

FDA rejects Regenxbio's Hunter syndrome gene therapy

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA.
Darren Incorvaia Feb 9, 2026 4:05pm
Sarepta Sarepta Therapeutics

Sarepta faces new scrutiny after 3rd patient death

Jul 18, 2025 10:19am
gene therapy AAV adeno-associated viruses

Neurogene details death in Rett syndrome gene therapy trial

May 16, 2025 3:00pm
AAV virus capsid

Vertex discontinues AAV research for gene therapies

May 2, 2025 6:22pm
dollar bills in multiple stacks

Lilly saves gene therapy biotech with $18M upfront deal

Apr 3, 2025 6:00pm
Roche

Roche bets up to $1B to expand Dyno gene therapy delivery pact

Oct 24, 2024 10:40am